CyVek nails down $3M for diagnostics test system

Connecticut startup CyVek has nailed down $3 million in new funding toward the development of a test system designed to handle molecular diagnostics, immunodiagnostics and bioassays for both drug discovery and clinical care use, MassHighTech is reporting. CyVek, which launched in 2010, disclosed the funding in a federal filing. The company raised $4 million in a Series B round almost two years ago, according to the article, including $802,000 from Connecticut Innovations. Story

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.